![](/img/cover-not-exists.png)
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
Mehnert, Janice M., Silk, Ann W., Wen, Yu, Lee, J. H., Dudek, Liesel, Jeong, Byeong-Seon, Li, Jiadong, Schenkel, Jason M., Sadimin, Evita, Kane, Michael, Lin, Hongxia, Shih, Weichung J., Zloza, AndrewLanguage:
english
Journal:
Pigment Cell & Melanoma Research
DOI:
10.1111/pcmr.12694
Date:
February, 2018
File:
PDF, 906 KB
english, 2018